PRL3-CNNM4 PPI-IN-1
PRL3-CNNM4 PPI IN 1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction and also inhibits PRL-mediated suppression of CNNM. PRL3-CNNM4 PPI IN 1 is capable of penetrating epithelial cell layers, exhibits metabolic stability, possesses favorable pharmacokinetic and pharmacodynamic properties, and holds potential for drug development based on this compound[1].
Product Specifications
CAS Number
40133-06-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/prl3-cnnm4-interaction-in-1.html
Purity
99.33
Smiles
O=C(O)C1=CC2=C(S1)CCC2
Molecular Formula
C8H8O2S
Molecular Weight
168.21
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Major Vault Protein (MVP) (1032), CF594 conjugate, 0.1mg/mL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (N/A), CF405S conjugate, 0.1mg/mL
Recombinant Human GFRA1/GDNFRA Protein (Fc Tag)